Actively Recruiting

Age: 18Years +
All Genders
NCT07245576

Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis

Led by AstraZeneca · Updated on 2026-04-21

600

Participants Needed

12

Research Sites

70 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Current diagnostic methods for asthma and chronic obstructive pulmonary disease mostly depend on pulmonary function tests, especially spirometry. While spirometry is a foundational tool, its diagnostic accuracy is often limited by the patient's ability to perform forceful breathing maneuvers, as well as technical and reproducibility challenges, and the need for proper equipment and training. These constraints can compromise effective diagnosis of asthma and COPD in primary care settings. Prompt and accurate diagnosis by primary care physicians is essential for better patient outcomes. Although variable airflow limitation often measured as a change in FEV1 after bronchodilator is a hallmark of asthma, inconsistencies in test quality and reversibility criteria create challenges in distinguishing asthma from COPD. These complexities highlight the need for alternative diagnostic tools beyond traditional spirometry. This observational study is designed to evaluate the diagnostic accuracy and technical feasibility of using oscillometry and FeNO testing in primary care for suspected asthma and COPD, compared to conventional specialist-based diagnostics. The study will be conducted across 6 countries in the MEA, Asia, and Latin America, with two hospital sites per country. Primary care physicians will be trained in oscillometry and FeNO testing using standardized protocols and tools such as the Ambulatory Lung Diagnosis System following GINA and GOLD guidelines. Eligible patients will provide consent, complete a history and symptom questionnaire, and undergo primary care-based assessment for a provisional diagnosis. If specialist assessment cannot occur the same day, it will be done within three days. No follow-up visits are planned. Study outcomes will inform the feasibility and accuracy of integrating these methods into routine care, aiming to improve the early and reliable diagnosis of asthma and COPD.

CONDITIONS

Official Title

Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years or older (or legal age of consent) with suspected asthma symptoms but no confirmed diagnosis
  • Patients 40 years or older with suspected COPD symptoms but no confirmed diagnosis
  • Patients capable of providing written informed consent
Not Eligible

You will not qualify if you...

  • Prior diagnosis of asthma or COPD
  • Use of inhaled corticosteroids in the last 6 months or oral corticosteroids in the last 3 months
  • Presence of diseases affecting lung function such as lung cancer, pneumonia, active tuberculosis, pulmonary embolism, or interstitial lung disease
  • Recent surgery affecting lung function, including thoracotomy, pneumothorax surgery, or thoracic drainage
  • Contraindications to spirometry or oscillometry tests or allergy to bronchodilator
  • Current pregnancy or breastfeeding
  • Patients unlikely to comply with study procedures or requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

Research Site

Buenos Aires, Argentina

Actively Recruiting

2

Research Site

Medoza, Argentina

Actively Recruiting

3

Research Site

Alexandria, Egypt

Not Yet Recruiting

4

Research Site

El Waili, Egypt

Not Yet Recruiting

5

Research Site

Monterrey, Mexico

Not Yet Recruiting

6

Research Site

Santiago de Quer Taro, Mexico

Not Yet Recruiting

7

Research Site

Riyadh, Saudi Arabia

Not Yet Recruiting

8

Research Site

Taichung, Taiwan

Not Yet Recruiting

9

Research Site

Taoyuan City, Taiwan

Not Yet Recruiting

10

Research Site

Dubai, United Arab Emirates

Not Yet Recruiting

11

Research Site

Hanoi, Vietnam

Not Yet Recruiting

12

Research Site

Ho Chi Minh City, Vietnam

Not Yet Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here